{"@context":"https://schema.org","@type":"NewsArticle","generatedAt":"2026-07-23T06:40:50.084Z","headline":"百时美施贵宝购买Nvidia Vera Rubin架构AI系统用于药物发现","description":"百时美施贵宝（BMS）将购买基于Nvidia Vera Rubin架构的DGX SuperPOD，成为首家采用该系统的生命科学公司。新集群包含八套DGX Vera Rubin NVL72系统，用于训练专有模型及化合物、蛋白质等科学数据的预测工作。BMS的\"Predict First\"方法已使临床试验候选药物筛选时间缩短20%-30%。","url":"https://www.aioga.com/news/cmrui8zig0atabi07bkkqfsmg/","mainEntityOfPage":"https://www.aioga.com/news/cmrui8zig0atabi07bkkqfsmg/","datePublished":"2026-07-21T10:00:00.000Z","dateModified":"2026-07-21T10:00:00.000Z","inLanguage":"zh-CN","publisher":{"@type":"NewsMediaOrganization","name":"Aioga","url":"https://www.aioga.com"},"citation":["https://www.artificialintelligence-news.com/news/bristol-myers-squibb-nvidia-ai-system-drug-discovery","https://aihot.virxact.com/items/cmrui8zig0atabi07bkkqfsmg"],"canonicalUrl":"https://www.aioga.com/news/cmrui8zig0atabi07bkkqfsmg/","directAnswer":{"@type":"Answer","text":"Aioga 编辑摘要：百时美施贵宝（BMS）将购买基于Nvidia Vera Rubin架构的DGX SuperPOD，成为首家采用该系统的生命科学公司。 Aioga 将其归入「行业动态」方向，重点关注它对真实使用和行业竞争的影响。","url":"https://www.aioga.com/news/cmrui8zig0atabi07bkkqfsmg/","dateCreated":"2026-07-21T10:00:00.000Z","author":{"@type":"Organization","@id":"https://www.aioga.com/authors/aioga-editorial/#editorial-team","name":"Aioga Editorial Team","url":"https://www.aioga.com/authors/aioga-editorial/"}},"evidence":[{"@type":"CreativeWork","name":"artificialintelligence-news.com source article","url":"https://www.artificialintelligence-news.com/news/bristol-myers-squibb-nvidia-ai-system-drug-discovery","datePublished":"2026-07-21T10:00:00.000Z","provider":{"@type":"Organization","name":"artificialintelligence-news.com","url":"https://www.artificialintelligence-news.com/news/bristol-myers-squibb-nvidia-ai-system-drug-discovery"}},{"@type":"CreativeWork","name":"AIHot archive record","url":"https://aihot.virxact.com/items/cmrui8zig0atabi07bkkqfsmg","datePublished":"2026-07-21T10:00:00.000Z","provider":{"@type":"Organization","name":"AIHot","url":"https://aihot.virxact.com/items/cmrui8zig0atabi07bkkqfsmg"}}],"aggregationSource":"Artificial Intelligence News（RSS）","originalPublisher":{"name":"artificialintelligence-news.com","url":"https://www.artificialintelligence-news.com/news/bristol-myers-squibb-nvidia-ai-system-drug-discovery"},"article":{"id":"cmrui8zig0atabi07bkkqfsmg","slug":"cmrui8zig0atabi07bkkqfsmg","url":"https://www.aioga.com/news/cmrui8zig0atabi07bkkqfsmg/","title":"百时美施贵宝购买Nvidia Vera Rubin架构AI系统用于药物发现","title_en":"Bristol Myers Squibb buys Nvidia AI system for drug discovery","summary":"百时美施贵宝（BMS）将购买基于Nvidia Vera Rubin架构的DGX SuperPOD，成为首家采用该系统的生命科学公司。新集群包含八套DGX Vera Rubin NVL72系统，用于训练专有模型及化合物、蛋白质等科学数据的预测工作。BMS的\"Predict First\"方法已使临床试验候选药物筛选时间缩短20%-30%。","source":"Artificial Intelligence News（RSS）","sourceUrl":"https://www.artificialintelligence-news.com/news/bristol-myers-squibb-nvidia-ai-system-drug-discovery","aiHotUrl":"https://aihot.virxact.com/items/cmrui8zig0atabi07bkkqfsmg","publishedAt":"2026-07-21T10:00:00.000Z","category":"行业动态","score":46,"selected":false,"articleBody":["Bristol Myers Squibb is purchasing an Nvidia DGX SuperPOD built on the chipmaker’s Vera Rubin architecture to support artificial intelligence use across its drug discovery and development operations.","The pharmaceutical company said it will be the first life sciences group to acquire a DGX SuperPOD based on Vera Rubin. Nvidia introduced the architecture earlier this year as the successor to its current generation of AI computing systems.","The new cluster will comprise eight DGX Vera Rubin NVL72 systems, with each rack-scale system combining Nvidia Vera central processing units and Rubin graphics processing units.","BMS will use the infrastructure to train proprietary models and run predictions across its research programmes. The system will support work involving compounds, proteins, and other scientific data.","Financial terms were not disclosed. The purchase expands BMS’s existing Nvidia infrastructure, which includes an older SuperPOD that company executives described as two or three generations behind Vera Rubin.","BMS has operated its existing DGX SuperPOD for about three years. The company plans to combine it with the Vera Rubin system in a shared computing environment accessible from its research sites worldwide.","The SuperPOD software stack can schedule training, prediction, and development workloads across the infrastructure. BMS said the expanded environment will give more scientists direct access to its computing resources.","Greg Meyers, BMS’s chief digital and technology officer, said computing requirements have increased as the company deploys larger AI models across its research organisation.","Erin Davis, vice president of research business insights and technology at BMS, said the existing infrastructure is operating at capacity. She attributed the demand to large-scale predictions involving large molecules and the development of internal foundation models.","Davis said the new system will not be limited to a small group of computational researchers. BMS plans to make it available across the research organisation without the waiting periods and access limits associated with its current infrastructure.","BMS said AI informs the design of every small-molecule programme and the majority of its large-molecule programmes. The technology is applied to target identification, lead optimisation, large-molecule predictions, and internal model development.","The company said AI-enabled target identification has reduced some manual research work by several weeks. Large-molecule prediction workloads are also contributing to demand for additional graphics processing capacity.","Robert Plenge, BMS’s chief research officer, said the new system will allow scientists to evaluate more potential drug candidates during the early stages of development.","“Maybe before we could do 10 and now we can do dozens,” Plenge said.","Computational screening allows researchers to assess potential compounds before selecting a smaller group for synthesis and laboratory testing.","BMS applies this approach through a method it calls “Predict First,” which uses model-generated predictions to exclude molecules that do not meet the required properties before candidates are selected for synthesis.","Payal Sheth, senior vice president of therapeutic discovery sciences at BMS, said researchers use the predictions to identify molecules with the required combination of properties.","“We use predictions as a way to prioritise synthesis of molecules with multi parameter optimisation,” Sheth said. “This ensures precious laboratory experiments are aligned with progressing molecules that have the highest probability of success.”","The method narrows the number of compounds sent for laboratory testing, allowing researchers to focus experiments on molecules that meet a programme’s predicted requirements.","BMS has also used AI to expand its library of CELMoD compounds, which are engineered to selectively degrade cancer-causing proteins. The company is studying the compounds in blood cancers and other diseases.","BMS said the modelling work helped researchers examine additional protein targets and potential compounds before deciding which candidates to pursue experimentally.","The company is also using AI tools to shorten the time required to produce medicines for clinical trials. Plenge said the process has already been reduced by between 20% and 30% and could reach 50% in the coming years.","He cited an experimental sickle cell disease treatment in early clinical development as one example of AI-supported research. Plenge said the treatment probably would not have been discovered without the company’s AI tools.","The figures refer to the time required to identify and produce candidates for clinical testing rather than their subsequent performance in trials.","The Vera Rubin system will also give researchers access to Nvidia’s BioNeMo Agent Toolkit for biological and drug-discovery applications.","BioNeMo provides tools for protein-structure prediction, molecular generation, molecular docking, sequence analysis, and genomics. It can also connect several computational tools within the same research workflow.","BMS executives said human researchers will continue to review model outputs and decide which compounds or programmes should advance.","BMS is introducing tools intended to reduce the specialist knowledge required to initiate complex computing tasks. The company said researchers will be able to start some prediction requests using natural-language instructions.","The environment will be managed through Nvidia Mission Control, whose functions include cluster provisioning, infrastructure monitoring, and workload management, according to BMS.","The unified infrastructure will allow data and model outputs generated at one site to be used by teams elsewhere. BMS said datasets from a programme in Lawrenceville, New Jersey, for example, can be incorporated into models used by researchers in San Diego.","Sheth said the shared environment is intended to retain information from experiments and research programmes across the organisation.","“The compute infrastructure is what connects all of our scientists together and ensures that our learnings are institutionalised,” Sheth said.","The two SuperPODs will operate through a common data environment, allowing teams at different sites to access shared datasets and model outputs. BMS said the environment will include information from experiments, clinical readouts, and research partnerships.","The company plans to allocate the new computing capacity across small- and large-molecule design, clinical research, and digital-twin applications. BMS did not provide details about the planned digital-twin work or the amount of capacity assigned to each area.","Meyers said the Vera Rubin system will provide more computing capacity relative to its electricity use. BMS and Nvidia said the eight-system cluster will deliver up to 10 times the performance per megawatt of the infrastructure it replaces.","“When you host these things, you have to pay an electric bill,” Meyers said. “Think of it as 10 times more compute capacity per watt spent … Electricity is not getting cheaper.”","BMS did not provide a specific deployment date or identify where the new system will be hosted.","(Photo by Chidera Faustina Okeke：https://unsplash.com/@thefourthwxll?utm_source=unsplash&utm_medium=referral&utm_content=creditCopyText)","See also: US public health agencies to test OpenAI and Anthropic AI models：https://www.artificialintelligence-news.com/news/openai-anthropic-public-health-ai/","Want to learn more about AI and big data from industry leaders? Check out AI & Big Data Expo：https://www.ai-expo.net/?utm_source=AI-News&utm_medium=Footer-banner&utm_campaign=world-series taking place in Amsterdam, California, and London. The comprehensive event is part of TechEx：https://techexevent.com/?utm_source=AI-News&utm_medium=Footer-banner&utm_campaign=world-series and is co-located with other leading technology events including the Cyber Security & Cloud Expo：https://cybersecuritycloudexpo.com/?utm_source=CloudTech-News&utm_medium=Footer-banner&utm_campaign=world-series. Click here：https://techexevent.com/?utm_source=AI-News&utm_medium=Footer-banner&utm_campaign=world-series for more information.","AI News is powered by TechForge Media：https://techforge.pub/?utm_source=AI-News&utm_medium=Footer-banner&utm_campaign=world-series. Explore other upcoming enterprise technology events and webinars here：https://techforge.pub/events/?utm_source=AI-News&utm_medium=Footer-banner&utm_campaign=world-series.","Muhammad Zulhusni：https://www.artificialintelligence-news.com/news/author/muhammadzulhusni/","Physical AI：https://www.artificialintelligence-news.com/categories/ai-and-us/physical-ai/","AI Business Strategy：https://www.artificialintelligence-news.com/categories/inside-ai/ai-business-strategy/, Artificial Intelligence：https://www.artificialintelligence-news.com/categories/artificial-intelligence/, Features：https://www.artificialintelligence-news.com/categories/features/, Finance AI：https://www.artificialintelligence-news.com/categories/ai-in-action/finance-ai/, World of Work：https://www.artificialintelligence-news.com/categories/ai-and-us/world-of-work/","Sponsored Content：https://www.artificialintelligence-news.com/categories/sponsored-content/","Healthcare & Wellness AI：https://www.artificialintelligence-news.com/categories/ai-in-action/healthcare-wellness-ai/","Artificial Intelligence：https://www.artificialintelligence-news.com/categories/artificial-intelligence/","AI in Action：https://www.artificialintelligence-news.com/categories/ai-in-action/","All our premium content and latest tech news delivered straight to your inbox","AI News is part of TechForge：https://techforge.pub/"],"articleImages":[{"sourceUrl":"https://www.artificialintelligence-news.com/wp-content/uploads/2026/06/image-300x37.png","alt":"Banner for AI & Big Data Expo by TechEx events.","afterParagraph":38,"url":"/media/articles/cmrui8zig0atabi07bkkqfsmg/1a537e7502a00912.png"},{"sourceUrl":"https://www.artificialintelligence-news.com/wp-content/uploads/2024/05/muhammadprof.jpeg","alt":"","afterParagraph":40,"url":"/media/articles/cmrui8zig0atabi07bkkqfsmg/244ae24f1a11ac92.jpg"},{"sourceUrl":"https://www.artificialintelligence-news.com/wp-content/uploads/2026/06/Airia-webinar.png","alt":"","afterParagraph":44,"url":"/media/articles/cmrui8zig0atabi07bkkqfsmg/09f94645ae1f29f3.png"},{"sourceUrl":"https://www.artificialintelligence-news.com/wp-content/uploads/2025/01/300x600-150x300.png","alt":"","afterParagraph":44,"url":"/media/articles/cmrui8zig0atabi07bkkqfsmg/84efdfaa93523a46.png"},{"sourceUrl":"https://www.artificialintelligence-news.com/wp-content/uploads/2026/07/Bristol-Myers-Squibb-buys-Nvidia-AI-system-for-drug-discovery-scaled-e1784603783132.jpg","alt":"Bristol Myers Squibb buys Nvidia AI system for drug discovery","afterParagraph":44,"url":"/media/articles/cmrui8zig0atabi07bkkqfsmg/4d06a9de75c52106.jpg"},{"sourceUrl":"https://www.artificialintelligence-news.com/wp-content/uploads/2026/07/1784472098908.jpeg","alt":"","afterParagraph":45,"url":"/media/articles/cmrui8zig0atabi07bkkqfsmg/6d66e21b1adeb114.jpg"}],"mediaStatus":"ok","articleBodyZh":["百时美施贵宝（Bristol Myers Squibb）正在购买基于芯片制造商Vera Rubin架构的Nvidia DGX SuperPOD，以支持其药物研发和开发业务中的人工智能应用。","这家制药公司表示，它将成为首个购买基于Vera Rubin架构的DGX SuperPOD的生命科学集团。Nvidia今年早些时候推出了该架构，作为其当前一代人工智能计算系统的继任者。","该新集群将包含八个DGX Vera Rubin NVL72系统，每个机架级系统结合了Nvidia Vera中央处理器和Rubin图形处理器。","BMS将使用该基础设施训练专有模型并在其研究项目中进行预测。该系统将支持涉及化合物、蛋白质及其他科学数据的工作。","财务条款尚未披露。此次购买扩展了BMS现有的Nvidia基础设施，该基础设施包括一个较旧的SuperPOD，公司的高管表示其技术相比Vera Rubin落后两到三代。","BMS已运营其现有的DGX SuperPOD约三年。公司计划将其与Vera Rubin系统结合，在全球研究站点可访问的共享计算环境中使用。","SuperPOD软件堆栈可以在整个基础设施中安排训练、预测和开发工作负载。BMS表示，扩展后的环境将使更多科学家可以直接访问其计算资源。","BMS首席数字与技术官Greg Meyers表示，随着公司在其研究组织中部署更大型的AI模型，计算需求已增加。","BMS研究业务洞察与技术副总裁Erin Davis表示，现有基础设施已满负荷运行。她将这一需求归因于涉及大分子的规模化预测以及内部基础模型的发展。","Davis表示，新系统不会仅限于少数计算研究人员使用。BMS计划在整个研究组织中提供该系统的访问，而无需像现有基础设施那样经历等待时间和访问限制。","BMS表示，人工智能（AI）为每个小分子项目和大多数大分子项目的设计提供信息。该技术应用于靶点识别、先导优化、大分子预测以及内部模型开发。","公司表示，利用AI进行的靶点识别已将某些人工研究工作缩短了数周。大分子预测工作量也增加了对额外图形处理能力的需求。","BMS首席研究官Robert Plenge表示，新系统将使科学家在开发早期阶段评估更多潜在药物候选分子。","“也许以前我们只能做10个，而现在我们可以做几十个，”Plenge说。","计算机筛选使研究人员在选择一小组进行合成和实验室测试之前评估潜在化合物。","BMS通过一种名为“Predict First”的方法应用这种策略，该方法使用模型生成的预测来排除不符合所需特性的分子，然后再选择候选分子进行合成。","BMS治疗发现科学高级副总裁Payal Sheth表示，研究人员使用这些预测来识别具有所需属性组合的分子。","“我们使用预测作为优先合成具有多参数优化分子的方式，”Sheth说。“这确保了宝贵的实验室实验与推进成功概率最高的分子保持一致。”","该方法缩减了送往实验室测试的化合物数量，使研究人员能够将实验集中在符合项目预测要求的分子上。","BMS还利用AI扩展了其CELMoD化合物库，这些化合物被设计用于选择性降解致癌蛋白。公司正在研究这些化合物在血液癌症及其他疾病中的应用。","BMS表示，这些建模工作帮助研究人员在决定实验性追求哪些候选分子之前，审查了额外的蛋白靶点和潜在化合物。","该公司还在使用人工智能工具来缩短用于临床试验药物生产所需的时间。Plenge表示，这一过程已经减少了20%到30%，未来几年可能达到50%。","他举了一个正在早期临床开发的实验性镰状细胞病治疗为例，这项研究得到了人工智能的支持。Plenge表示，如果没有公司的人工智能工具，这种治疗可能不会被发现。","这些数字指的是识别和生产临床试验候选药物所需的时间，而不是它们在试验中的后续表现。","Vera Rubin系统还将让研究人员访问Nvidia用于生物和药物发现应用的BioNeMo Agent工具包。","BioNeMo提供蛋白结构预测、分子生成、分子对接、序列分析和基因组学的工具。它还可以在同一研究工作流程中连接多个计算工具。","BMS高管表示，人类研究人员将继续审核模型输出并决定哪些化合物或项目应继续推进。","BMS正在引入旨在减少启动复杂计算任务所需专业知识的工具。公司表示，研究人员将能够使用自然语言指令发起一些预测请求。","据BMS称，该环境将通过Nvidia Mission Control进行管理，其功能包括集群配置、基础设施监控和工作负载管理。","统一的基础设施将允许在一个地点生成的数据和模型输出被其他团队使用。例如，BMS表示，新泽西州劳伦斯维尔项目的数据集可以被圣地亚哥的研究人员用于模型中。","Sheth表示，共享环境旨在保留整个组织的实验和研究项目信息。","Sheth表示：“计算基础设施是将我们所有科学家联系在一起并确保我们的经验得以制度化的关键。”","这两个超级POD将通过一个共同的数据环境运行，使不同地点的团队能够访问共享的数据集和模型输出。BMS 表示，环境将包括来自实验、临床结果和研究合作的信息。","该公司计划将新增计算能力分配于小分子和大分子设计、临床研究以及数字孪生应用。BMS 没有提供关于计划中的数字孪生工作的详细信息，也没有说明每个领域分配的计算能力。","Meyers 表示，Vera Rubin 系统将在电力使用上提供更多的计算能力。BMS 和 Nvidia 表示，这八系统集群将提供高达其替代基础设施每兆瓦电力性能的十倍。","“当你托管这些设备时，你必须支付电费，”Meyers 说。“可以把它看作每瓦电力花费提供十倍的计算能力……电力不会变得更便宜。”","BMS 没有提供具体的部署日期，也没有说明新系统的托管地点。","（照片由 Chidera Faustina Okeke 提供：https://unsplash.com/@thefourthwxll?utm_source=unsplash&utm_medium=referral&utm_content=creditCopyText）","另请参阅：美国公共卫生机构将测试 OpenAI 和 Anthropic 的人工智能模型：https://www.artificialintelligence-news.com/news/openai-anthropic-public-health-ai/","想了解行业领导者关于人工智能和大数据的更多信息？请查看 AI & Big Data Expo：https://www.ai-expo.net/?utm_source=AI-News&utm_medium=Footer-banner&utm_campaign=world-series，该活动将在阿姆斯特丹、加州和伦敦举行。该综合性活动是 TechEx 的一部分：https://techexevent.com/?utm_source=AI-News&utm_medium=Footer-banner&utm_campaign=world-series，并与其他领先技术活动共同举行，包括网络安全与云计算博览会：https://cybersecuritycloudexpo.com/?utm_source=CloudTech-News&utm_medium=Footer-banner&utm_campaign=world-series。点击这里了解更多信息：https://techexevent.com/?utm_source=AI-News&utm_medium=Footer-banner&utm_campaign=world-series。","AI新闻由TechForge Media提供动力：https://techforge.pub/?utm_source=AI-News&utm_medium=Footer-banner&utm_campaign=world-series。探索其他即将举行的企业技术活动和网络研讨会：https://techforge.pub/events/?utm_source=AI-News&utm_medium=Footer-banner&utm_campaign=world-series。","Muhammad Zulhusni：https://www.artificialintelligence-news.com/news/author/muhammadzulhusni/","物理AI：https://www.artificialintelligence-news.com/categories/ai-and-us/physical-ai/","AI商业策略：https://www.artificialintelligence-news.com/categories/inside-ai/ai-business-strategy/，人工智能：https://www.artificialintelligence-news.com/categories/artificial-intelligence/，特色报道：https://www.artificialintelligence-news.com/categories/features/，金融AI：https://www.artificialintelligence-news.com/categories/ai-in-action/finance-ai/，职场世界：https://www.artificialintelligence-news.com/categories/ai-and-us/world-of-work/","赞助内容：https://www.artificialintelligence-news.com/categories/sponsored-content/","医疗与健康AI：https://www.artificialintelligence-news.com/categories/ai-in-action/healthcare-wellness-ai/","人工智能：https://www.artificialintelligence-news.com/categories/artificial-intelligence/","AI行动：https://www.artificialintelligence-news.com/categories/ai-in-action/","我们所有的优质内容和最新科技新闻直接送达您的邮箱","AI新闻是TechForge的一部分：https://techforge.pub/"],"translationStatus":"translated","bodyOrigin":"source-page","editorial":{"summary":"Aioga 编辑摘要：百时美施贵宝（BMS）将购买基于Nvidia Vera Rubin架构的DGX SuperPOD，成为首家采用该系统的生命科学公司。 Aioga 将其归入「行业动态」方向，重点关注它对真实使用和行业竞争的影响。","background":"背景分析：公司与行业类动态需要放在竞争格局、商业化路径、资本信号和监管环境中观察，单条公告不能代表最终结果。","viewpoint":"Aioga 判断：这条动态更适合作为行业观察信号，当前信息足以建立线索，但不足以推导长期结论。","implications":"影响分析：对相关团队而言，短期应先核对来源、可用范围和实际成本，再判断是否值得接入或跟进。","nextStep":"后续观察：继续观察官方文件、合作落地、收入或用户信号、竞品动作和监管后续。","evidenceRefs":["title","summary","articleBody"],"confidence":"medium","status":"published","aiGenerated":false,"autoApproved":true,"generatedBy":"rule-safe-fallback","generatedAt":"2026-07-23T06:49:19.078Z","sourceHash":"c4634aeb4cdcacb7","validation":{"passed":true,"mode":"rule-safe-fallback","checks":["schema","length","source-attribution","no-html"]}},"tags":["行业动态","Artificial Intelligence News（RSS）"],"translations":{"zh-CN":{"title":"百时美施贵宝购买Nvidia Vera Rubin架构AI系统用于药物发现","summary":"百时美施贵宝（BMS）将购买基于Nvidia Vera Rubin架构的DGX SuperPOD，成为首家采用该系统的生命科学公司。新集群包含八套DGX Vera Rubin NVL72系统，用于训练专有模型及化合物、蛋白质等科学数据的预测工作。BMS的\"Predict First\"方法已使临床试验候选药物筛选时间缩短20%-30%。","category":"行业动态","source":"artificialintelligence-news.com","aggregationSource":"Artificial Intelligence News（RSS）","pageTitle":"百时美施贵宝购买Nvidia Vera Rubin架构AI系统用于药物发现 - Aioga AI资讯","description":"百时美施贵宝（BMS）将购买基于Nvidia Vera Rubin架构的DGX SuperPOD，成为首家采用该系统的生命科学公司。新集群包含八套DGX Vera Rubin NVL72系统，用于训练专有模型及化合物、蛋白质等科学数据的预测工作。BMS的\"Predict First\"方法已使临床试验候选药物筛选时间缩短20%-30%。","url":"https://www.aioga.com/news/cmrui8zig0atabi07bkkqfsmg/"},"en":{"title":"Bristol Myers Squibb buys Nvidia AI system for drug discovery","summary":"Aioga tracks this update from Artificial Intelligence News（RSS） under Industry. 百时美施贵宝（BMS）将购买基于Nvidia Vera Rubin架构的DGX SuperPOD，成为首家采用该系统的生命科学公司。新集群包含八套DGX Vera Rubin NVL72系统，用于训练专有模型及化合物、蛋白质等科学数据的预测工作。BMS的\"Predict First\"方法已使临床试验候选药物筛选时间缩短20%-30%。","category":"Industry","source":"artificialintelligence-news.com","aggregationSource":"Artificial Intelligence News（RSS）","pageTitle":"Bristol Myers Squibb buys Nvidia AI system for drug discovery - Aioga AI News","description":"Aioga tracks this update from Artificial Intelligence News（RSS） under Industry. 百时美施贵宝（BMS）将购买基于Nvidia Vera Rubin架构的DGX SuperPOD，成为首家采用该系统的生命科学公司。新集群包含八套DGX Vera Rubin NVL72系统，用于训练...","url":"https://www.aioga.com/en/news/cmrui8zig0atabi07bkkqfsmg/"},"ja":{"title":"百时美施贵宝购买Nvidia Vera Rubin架构AI系统用于药物发现","summary":"Aiogaは「業界動向」の動きとして、Artificial Intelligence News（RSS） からの更新を追跡しています。百时美施贵宝（BMS）将购买基于Nvidia Vera Rubin架构的DGX SuperPOD，成为首家采用该系统的生命科学公司。新集群包含八套DGX Vera Rubin NVL72系统，用于训练专有模型及化合物、蛋白质等科学数据的预测工作。BMS的\"Predict First\"方法已使临床试验候选药物筛选时间缩短20%-30%。","category":"業界動向","source":"artificialintelligence-news.com","aggregationSource":"Artificial Intelligence News（RSS）","pageTitle":"百时美施贵宝购买Nvidia Vera Rubin架构AI系统用于药物发现 - Aioga AIニュース","description":"Aiogaは「業界動向」の動きとして、Artificial Intelligence News（RSS） からの更新を追跡しています。百时美施贵宝（BMS）将购买基于Nvidia Vera Rubin架构的DGX SuperPOD，成为首家采用该系统的生命科学公司。新集群包含八套DGX Vera Rubin NVL72系统，用于训练专有模型及化合物、蛋白质等...","url":"https://www.aioga.com/ja/news/cmrui8zig0atabi07bkkqfsmg/"},"ko":{"title":"百时美施贵宝购买Nvidia Vera Rubin架构AI系统用于药物发现","summary":"Aioga는 Artificial Intelligence News（RSS）의 업데이트를 업계 동향 흐름으로 추적합니다. 百时美施贵宝（BMS）将购买基于Nvidia Vera Rubin架构的DGX SuperPOD，成为首家采用该系统的生命科学公司。新集群包含八套DGX Vera Rubin NVL72系统，用于训练专有模型及化合物、蛋白质等科学数据的预测工作。BMS的\"Predict First\"方法已使临床试验候选药物筛选时间缩短20%-30%。","category":"업계 동향","source":"artificialintelligence-news.com","aggregationSource":"Artificial Intelligence News（RSS）","pageTitle":"百时美施贵宝购买Nvidia Vera Rubin架构AI系统用于药物发现 - Aioga AI 뉴스","description":"Aioga는 Artificial Intelligence News（RSS）의 업데이트를 업계 동향 흐름으로 추적합니다. 百时美施贵宝（BMS）将购买基于Nvidia Vera Rubin架构的DGX SuperPOD，成为首家采用该系统的生命科学公司。新集群包含八套DGX Vera Rubin NVL72系统，用于训练专有模型及化合物、蛋白质等科...","url":"https://www.aioga.com/ko/news/cmrui8zig0atabi07bkkqfsmg/"},"es":{"title":"百时美施贵宝购买Nvidia Vera Rubin架构AI系统用于药物发现","summary":"Aioga sigue esta actualización de Artificial Intelligence News（RSS） dentro de Industria. 百时美施贵宝（BMS）将购买基于Nvidia Vera Rubin架构的DGX SuperPOD，成为首家采用该系统的生命科学公司。新集群包含八套DGX Vera Rubin NVL72系统，用于训练专有模型及化合物、蛋白质等科学数据的预测工作。BMS的\"Predict First\"方法已使临床试验候选药物筛选时间缩短20%-30%。","category":"Industria","source":"artificialintelligence-news.com","aggregationSource":"Artificial Intelligence News（RSS）","pageTitle":"百时美施贵宝购买Nvidia Vera Rubin架构AI系统用于药物发现 - Aioga Noticias de IA","description":"Aioga sigue esta actualización de Artificial Intelligence News（RSS） dentro de Industria. 百时美施贵宝（BMS）将购买基于Nvidia Vera Rubin架构的DGX SuperPOD，成为首家采用该系统的生命科学公司。新集群包含八套DGX Vera Rubin NVL...","url":"https://www.aioga.com/es/news/cmrui8zig0atabi07bkkqfsmg/"},"fr":{"title":"百时美施贵宝购买Nvidia Vera Rubin架构AI系统用于药物发现","summary":"Aioga suit cette mise à jour de Artificial Intelligence News（RSS） dans la catégorie Industrie. 百时美施贵宝（BMS）将购买基于Nvidia Vera Rubin架构的DGX SuperPOD，成为首家采用该系统的生命科学公司。新集群包含八套DGX Vera Rubin NVL72系统，用于训练专有模型及化合物、蛋白质等科学数据的预测工作。BMS的\"Predict First\"方法已使临床试验候选药物筛选时间缩短20%-30%。","category":"Industrie","source":"artificialintelligence-news.com","aggregationSource":"Artificial Intelligence News（RSS）","pageTitle":"百时美施贵宝购买Nvidia Vera Rubin架构AI系统用于药物发现 - Aioga Actualités IA","description":"Aioga suit cette mise à jour de Artificial Intelligence News（RSS） dans la catégorie Industrie. 百时美施贵宝（BMS）将购买基于Nvidia Vera Rubin架构的DGX SuperPOD，成为首家采用该系统的生命科学公司。新集群包含八套DGX Vera Rub...","url":"https://www.aioga.com/fr/news/cmrui8zig0atabi07bkkqfsmg/"},"de":{"title":"百时美施贵宝购买Nvidia Vera Rubin架构AI系统用于药物发现","summary":"Aioga tracks this update from Artificial Intelligence News（RSS） under 行业动态. 百时美施贵宝（BMS）将购买基于Nvidia Vera Rubin架构的DGX SuperPOD，成为首家采用该系统的生命科学公司。新集群包含八套DGX Vera Rubin NVL72系统，用于训练专有模型及化合物、蛋白质等科学数据的预测工作。BMS的\"Predict First\"方法已使临床试验候选药物筛选时间缩短20%-30%。","category":"行业动态","source":"artificialintelligence-news.com","aggregationSource":"Artificial Intelligence News（RSS）","pageTitle":"百时美施贵宝购买Nvidia Vera Rubin架构AI系统用于药物发现 - Aioga KI-News","description":"Aioga tracks this update from Artificial Intelligence News（RSS） under 行业动态. 百时美施贵宝（BMS）将购买基于Nvidia Vera Rubin架构的DGX SuperPOD，成为首家采用该系统的生命科学公司。新集群包含八套DGX Vera Rubin NVL72系统，用于训练专有模型...","url":"https://www.aioga.com/de/news/cmrui8zig0atabi07bkkqfsmg/"},"pt-BR":{"title":"百时美施贵宝购买Nvidia Vera Rubin架构AI系统用于药物发现","summary":"Aioga tracks this update from Artificial Intelligence News（RSS） under 行业动态. 百时美施贵宝（BMS）将购买基于Nvidia Vera Rubin架构的DGX SuperPOD，成为首家采用该系统的生命科学公司。新集群包含八套DGX Vera Rubin NVL72系统，用于训练专有模型及化合物、蛋白质等科学数据的预测工作。BMS的\"Predict First\"方法已使临床试验候选药物筛选时间缩短20%-30%。","category":"行业动态","source":"artificialintelligence-news.com","aggregationSource":"Artificial Intelligence News（RSS）","pageTitle":"百时美施贵宝购买Nvidia Vera Rubin架构AI系统用于药物发现 - Aioga Notícias de IA","description":"Aioga tracks this update from Artificial Intelligence News（RSS） under 行业动态. 百时美施贵宝（BMS）将购买基于Nvidia Vera Rubin架构的DGX SuperPOD，成为首家采用该系统的生命科学公司。新集群包含八套DGX Vera Rubin NVL72系统，用于训练专有模型...","url":"https://www.aioga.com/pt-BR/news/cmrui8zig0atabi07bkkqfsmg/"},"ru":{"title":"百时美施贵宝购买Nvidia Vera Rubin架构AI系统用于药物发现","summary":"Aioga tracks this update from Artificial Intelligence News（RSS） under 行业动态. 百时美施贵宝（BMS）将购买基于Nvidia Vera Rubin架构的DGX SuperPOD，成为首家采用该系统的生命科学公司。新集群包含八套DGX Vera Rubin NVL72系统，用于训练专有模型及化合物、蛋白质等科学数据的预测工作。BMS的\"Predict First\"方法已使临床试验候选药物筛选时间缩短20%-30%。","category":"行业动态","source":"artificialintelligence-news.com","aggregationSource":"Artificial Intelligence News（RSS）","pageTitle":"百时美施贵宝购买Nvidia Vera Rubin架构AI系统用于药物发现 - Aioga Новости ИИ","description":"Aioga tracks this update from Artificial Intelligence News（RSS） under 行业动态. 百时美施贵宝（BMS）将购买基于Nvidia Vera Rubin架构的DGX SuperPOD，成为首家采用该系统的生命科学公司。新集群包含八套DGX Vera Rubin NVL72系统，用于训练专有模型...","url":"https://www.aioga.com/ru/news/cmrui8zig0atabi07bkkqfsmg/"},"ar":{"title":"百时美施贵宝购买Nvidia Vera Rubin架构AI系统用于药物发现","summary":"Aioga tracks this update from Artificial Intelligence News（RSS） under 行业动态. 百时美施贵宝（BMS）将购买基于Nvidia Vera Rubin架构的DGX SuperPOD，成为首家采用该系统的生命科学公司。新集群包含八套DGX Vera Rubin NVL72系统，用于训练专有模型及化合物、蛋白质等科学数据的预测工作。BMS的\"Predict First\"方法已使临床试验候选药物筛选时间缩短20%-30%。","category":"行业动态","source":"artificialintelligence-news.com","aggregationSource":"Artificial Intelligence News（RSS）","pageTitle":"百时美施贵宝购买Nvidia Vera Rubin架构AI系统用于药物发现 - Aioga أخبار الذكاء الاصطناعي","description":"Aioga tracks this update from Artificial Intelligence News（RSS） under 行业动态. 百时美施贵宝（BMS）将购买基于Nvidia Vera Rubin架构的DGX SuperPOD，成为首家采用该系统的生命科学公司。新集群包含八套DGX Vera Rubin NVL72系统，用于训练专有模型...","url":"https://www.aioga.com/ar/news/cmrui8zig0atabi07bkkqfsmg/"},"hi":{"title":"百时美施贵宝购买Nvidia Vera Rubin架构AI系统用于药物发现","summary":"Aioga tracks this update from Artificial Intelligence News（RSS） under 行业动态. 百时美施贵宝（BMS）将购买基于Nvidia Vera Rubin架构的DGX SuperPOD，成为首家采用该系统的生命科学公司。新集群包含八套DGX Vera Rubin NVL72系统，用于训练专有模型及化合物、蛋白质等科学数据的预测工作。BMS的\"Predict First\"方法已使临床试验候选药物筛选时间缩短20%-30%。","category":"行业动态","source":"artificialintelligence-news.com","aggregationSource":"Artificial Intelligence News（RSS）","pageTitle":"百时美施贵宝购买Nvidia Vera Rubin架构AI系统用于药物发现 - Aioga AI समाचार","description":"Aioga tracks this update from Artificial Intelligence News（RSS） under 行业动态. 百时美施贵宝（BMS）将购买基于Nvidia Vera Rubin架构的DGX SuperPOD，成为首家采用该系统的生命科学公司。新集群包含八套DGX Vera Rubin NVL72系统，用于训练专有模型...","url":"https://www.aioga.com/hi/news/cmrui8zig0atabi07bkkqfsmg/"},"it":{"title":"百时美施贵宝购买Nvidia Vera Rubin架构AI系统用于药物发现","summary":"Aioga tracks this update from Artificial Intelligence News（RSS） under 行业动态. 百时美施贵宝（BMS）将购买基于Nvidia Vera Rubin架构的DGX SuperPOD，成为首家采用该系统的生命科学公司。新集群包含八套DGX Vera Rubin NVL72系统，用于训练专有模型及化合物、蛋白质等科学数据的预测工作。BMS的\"Predict First\"方法已使临床试验候选药物筛选时间缩短20%-30%。","category":"行业动态","source":"artificialintelligence-news.com","aggregationSource":"Artificial Intelligence News（RSS）","pageTitle":"百时美施贵宝购买Nvidia Vera Rubin架构AI系统用于药物发现 - Aioga Notizie IA","description":"Aioga tracks this update from Artificial Intelligence News（RSS） under 行业动态. 百时美施贵宝（BMS）将购买基于Nvidia Vera Rubin架构的DGX SuperPOD，成为首家采用该系统的生命科学公司。新集群包含八套DGX Vera Rubin NVL72系统，用于训练专有模型...","url":"https://www.aioga.com/it/news/cmrui8zig0atabi07bkkqfsmg/"},"nl":{"title":"百时美施贵宝购买Nvidia Vera Rubin架构AI系统用于药物发现","summary":"Aioga tracks this update from Artificial Intelligence News（RSS） under 行业动态. 百时美施贵宝（BMS）将购买基于Nvidia Vera Rubin架构的DGX SuperPOD，成为首家采用该系统的生命科学公司。新集群包含八套DGX Vera Rubin NVL72系统，用于训练专有模型及化合物、蛋白质等科学数据的预测工作。BMS的\"Predict First\"方法已使临床试验候选药物筛选时间缩短20%-30%。","category":"行业动态","source":"artificialintelligence-news.com","aggregationSource":"Artificial Intelligence News（RSS）","pageTitle":"百时美施贵宝购买Nvidia Vera Rubin架构AI系统用于药物发现 - Aioga AI-nieuws","description":"Aioga tracks this update from Artificial Intelligence News（RSS） under 行业动态. 百时美施贵宝（BMS）将购买基于Nvidia Vera Rubin架构的DGX SuperPOD，成为首家采用该系统的生命科学公司。新集群包含八套DGX Vera Rubin NVL72系统，用于训练专有模型...","url":"https://www.aioga.com/nl/news/cmrui8zig0atabi07bkkqfsmg/"},"tr":{"title":"百时美施贵宝购买Nvidia Vera Rubin架构AI系统用于药物发现","summary":"Aioga tracks this update from Artificial Intelligence News（RSS） under 行业动态. 百时美施贵宝（BMS）将购买基于Nvidia Vera Rubin架构的DGX SuperPOD，成为首家采用该系统的生命科学公司。新集群包含八套DGX Vera Rubin NVL72系统，用于训练专有模型及化合物、蛋白质等科学数据的预测工作。BMS的\"Predict First\"方法已使临床试验候选药物筛选时间缩短20%-30%。","category":"行业动态","source":"artificialintelligence-news.com","aggregationSource":"Artificial Intelligence News（RSS）","pageTitle":"百时美施贵宝购买Nvidia Vera Rubin架构AI系统用于药物发现 - Aioga AI Haberleri","description":"Aioga tracks this update from Artificial Intelligence News（RSS） under 行业动态. 百时美施贵宝（BMS）将购买基于Nvidia Vera Rubin架构的DGX SuperPOD，成为首家采用该系统的生命科学公司。新集群包含八套DGX Vera Rubin NVL72系统，用于训练专有模型...","url":"https://www.aioga.com/tr/news/cmrui8zig0atabi07bkkqfsmg/"},"vi":{"title":"百时美施贵宝购买Nvidia Vera Rubin架构AI系统用于药物发现","summary":"Aioga tracks this update from Artificial Intelligence News（RSS） under 行业动态. 百时美施贵宝（BMS）将购买基于Nvidia Vera Rubin架构的DGX SuperPOD，成为首家采用该系统的生命科学公司。新集群包含八套DGX Vera Rubin NVL72系统，用于训练专有模型及化合物、蛋白质等科学数据的预测工作。BMS的\"Predict First\"方法已使临床试验候选药物筛选时间缩短20%-30%。","category":"行业动态","source":"artificialintelligence-news.com","aggregationSource":"Artificial Intelligence News（RSS）","pageTitle":"百时美施贵宝购买Nvidia Vera Rubin架构AI系统用于药物发现 - Tin tức AI Aioga","description":"Aioga tracks this update from Artificial Intelligence News（RSS） under 行业动态. 百时美施贵宝（BMS）将购买基于Nvidia Vera Rubin架构的DGX SuperPOD，成为首家采用该系统的生命科学公司。新集群包含八套DGX Vera Rubin NVL72系统，用于训练专有模型...","url":"https://www.aioga.com/vi/news/cmrui8zig0atabi07bkkqfsmg/"},"id":{"title":"百时美施贵宝购买Nvidia Vera Rubin架构AI系统用于药物发现","summary":"Aioga tracks this update from Artificial Intelligence News（RSS） under 行业动态. 百时美施贵宝（BMS）将购买基于Nvidia Vera Rubin架构的DGX SuperPOD，成为首家采用该系统的生命科学公司。新集群包含八套DGX Vera Rubin NVL72系统，用于训练专有模型及化合物、蛋白质等科学数据的预测工作。BMS的\"Predict First\"方法已使临床试验候选药物筛选时间缩短20%-30%。","category":"行业动态","source":"artificialintelligence-news.com","aggregationSource":"Artificial Intelligence News（RSS）","pageTitle":"百时美施贵宝购买Nvidia Vera Rubin架构AI系统用于药物发现 - Berita AI Aioga","description":"Aioga tracks this update from Artificial Intelligence News（RSS） under 行业动态. 百时美施贵宝（BMS）将购买基于Nvidia Vera Rubin架构的DGX SuperPOD，成为首家采用该系统的生命科学公司。新集群包含八套DGX Vera Rubin NVL72系统，用于训练专有模型...","url":"https://www.aioga.com/id/news/cmrui8zig0atabi07bkkqfsmg/"},"th":{"title":"百时美施贵宝购买Nvidia Vera Rubin架构AI系统用于药物发现","summary":"Aioga tracks this update from Artificial Intelligence News（RSS） under 行业动态. 百时美施贵宝（BMS）将购买基于Nvidia Vera Rubin架构的DGX SuperPOD，成为首家采用该系统的生命科学公司。新集群包含八套DGX Vera Rubin NVL72系统，用于训练专有模型及化合物、蛋白质等科学数据的预测工作。BMS的\"Predict First\"方法已使临床试验候选药物筛选时间缩短20%-30%。","category":"行业动态","source":"artificialintelligence-news.com","aggregationSource":"Artificial Intelligence News（RSS）","pageTitle":"百时美施贵宝购买Nvidia Vera Rubin架构AI系统用于药物发现 - ข่าว AI Aioga","description":"Aioga tracks this update from Artificial Intelligence News（RSS） under 行业动态. 百时美施贵宝（BMS）将购买基于Nvidia Vera Rubin架构的DGX SuperPOD，成为首家采用该系统的生命科学公司。新集群包含八套DGX Vera Rubin NVL72系统，用于训练专有模型...","url":"https://www.aioga.com/th/news/cmrui8zig0atabi07bkkqfsmg/"},"pl":{"title":"百时美施贵宝购买Nvidia Vera Rubin架构AI系统用于药物发现","summary":"Aioga tracks this update from Artificial Intelligence News（RSS） under 行业动态. 百时美施贵宝（BMS）将购买基于Nvidia Vera Rubin架构的DGX SuperPOD，成为首家采用该系统的生命科学公司。新集群包含八套DGX Vera Rubin NVL72系统，用于训练专有模型及化合物、蛋白质等科学数据的预测工作。BMS的\"Predict First\"方法已使临床试验候选药物筛选时间缩短20%-30%。","category":"行业动态","source":"artificialintelligence-news.com","aggregationSource":"Artificial Intelligence News（RSS）","pageTitle":"百时美施贵宝购买Nvidia Vera Rubin架构AI系统用于药物发现 - Aioga Wiadomości AI","description":"Aioga tracks this update from Artificial Intelligence News（RSS） under 行业动态. 百时美施贵宝（BMS）将购买基于Nvidia Vera Rubin架构的DGX SuperPOD，成为首家采用该系统的生命科学公司。新集群包含八套DGX Vera Rubin NVL72系统，用于训练专有模型...","url":"https://www.aioga.com/pl/news/cmrui8zig0atabi07bkkqfsmg/"}}}}